Prevalence of metabolic syndrome in the indigenous population, aged 19 to 69 years, from Jaguapiru Village, Dourados (MS), Brazil

Ethnicity and Disease

Volumn 21, Issue 3, 2011, Pages 301-306

  De Oliveira, Geraldo Ferreira ^a   De Oliveira, Teresinha Regina Ribeiro ^a   Rodrigues, Fernanda França ^b   Corrêa, Lincoln Ferreira ^b   De Arruda, Thyego Barreto ^b   Casulari, Luiz Augusto ^c  

^a Clinical Medicine Department   (Brazil)

^b UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^c HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

Diabetes mellitus; Hypertension; Metabolic syndrome; Obesity; South American Indians

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAZIL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RANDOM SAMPLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTHROPOMETRY; BRAZIL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INDIANS, SOUTH AMERICAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 80054859538     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Meigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care. 2002;8(s11):283-292.
2. Mohamed-Ali V, Pinkney, Coppack SW. Adipose tissue as an endocrine and paracrine organ. J Obes Relat Metab Disord. 1998;22: 1145-1158. (Pubitemid 28548534)
3. Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand. 2005;183:13-30. (Pubitemid 40188033)
4. Saydah SH, Loria CM, Eberhardt MS. Subclinical state of glucose intolerance and risk of death in the U.S. Diabetes Care. 2001;24(3):447-453. (Pubitemid 32198411)
5. St-Pierre AC, Ruel IL, Cantin B, et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation. 2001;104:2295-2299. (Pubitemid 33049511)
6. Brunzell JD, Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care. 1999;22(Suppl 3):C10-C13. (Pubitemid 29164911)
7. Ross R. Mechanisms of disease: arteriosclerosis - an inflammatory disease. N Eng J Med. 1999;340:115-126.
8. Collins R, Peto R, MacMahon S, et al. Blood pressure stroke, and coronary heart disease.Part 2: Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335: 827-838. (Pubitemid 20113741)
9. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and allcauses: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309-314. (Pubitemid 38469801)
10. Salaroli LB, Barbosa GC, Mill JG, Molina MCB. Prevalência de síndrome metabólica em estudo de base populacional, Vitória, ES - Brasil. Arq Bras Endocrinol Metab. 2007;51(7): 1143-1152.
11. Cardoso AM, Mattos IE, Koifman RJ. Prevaléncia de fatores de risco para doenças cardiovasculares na população Guarani-Mbyá do Estado do Rio de Janeiro. Cad Saúde Pública. 2001;17(2):345-354.
12. Gimeno SGA, Rodrigues D, Pagliaro H, Cano EM, Lima EES, Baruzzi RG. Perfil metabólico e antropométrico de índios Aruák, Mehináku, Waurá e Yawalapití, Alto Xingu, Brasil Central, 2000/2002. Cad Saúde Pública. 2007;23(8):1946-4.
13. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366:1059-1062. (Pubitemid 41338752)
14. Fundação Nacional do Índio (FUNAI), Índios do Brasil. Available at: http://www.funai,gov. br. Last accessed on January 17, 2010.
15. Callegari-Jacques SM. Bioestatística: Princípios e Aplicações. 1st ed. Porto Alegre: Artmed; 2003.
16. Velásquez-Meléndez G, Gazzinelli A, Corrêa- Oliveira R, Pimenta AM, Kac G. Prevalence of metabolic syndrome in a rural area of Brazil. São Paulo Med J. 2007;125(3):155-162.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
18. Rosenbaum P, Gimeno SGA, Sanudo A, Franco LJ, Ferreira SLG. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians. Diabetes Obes Metab. 2005;7(4):352-359. (Pubitemid 40916577)
19. Oliveira EP, Souza MLA, Lima MDA. Prevale ̂ncia de síndrome metabólica em uma área rural do semi-árido baiano. Arq Bras Endocrinol Metab. 2006;50(3):456-465. (Pubitemid 44298523)
20. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002; 3:551.
21. Misra KB, Endemann SW, Ayer M. Measures of obesity and metabolic syndrome in Indian Americans in Northern California. Ethn Dis. 2006;16(2):331-337. (Pubitemid 46952628)
22. Park HS, Kim SM, Lee JS, et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes Metab. 2007;9: 50-58. (Pubitemid 44921041)
23. Mattsson N, Rönnemaa T, Juonala M. Wikari JSA, Raitakari OT. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med. 2007;261:158-169.
24. Weis R, Dziura J, Burget TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Eng J Med. 2004;350: 2362-2374. (Pubitemid 38702847)
25. Egger G. The case for using waist to hip ratio measurements in routine medical checks. Med J Aust. 1992;156:280-285.
26. Fujimoto WY, Bergstrom RW, Bokyo EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. Diabetes Care. 1999;22:1808-1812.
27. Caballero AE. Endothelial dysfunction in obesity and insulin resistance. Am J Cardiol. 2003;11:1278-1289.
28. Kabir M, Catalano KJ, Ananthnarayan S, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2005;288: 454-461.
29. Capelli JCS, Koifman S. Avaliação do estado nutricional da comunidade indígena Parkatêjê, Bom Jesus do Tocantins, Pará, Brás. Cad Saúde Pública. 2001;17(2):433-437.
30. Saad MBNL. Saúde e Nutrição Terena: Sobrepeso e Obesidade. Dissertação de Mestrado. Universidade Federal de Mato Grosso do Sul. Campo Grande, MS, 2005:95.
31. Silva DA, Felisbino-Mendes MS, Pimenta AM, Gazzinelli S. Hac G, Velásquez-Meléndez G. Distúrbios metabólicos e adiposidade em uma população rural. Arq Bras Endocrinol Metab. 2008;52(3):489-498.
32. Chittleborough CR, Grant JF, Phillips PJ, Taylor AW. The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health. 2006;121(2):92-99.
33. Gugelmin SA, Santos RV. Ecologia humana e antropometria nutricional de índios adultos Xavánte em Mato Grosso, Brasil. Cad Saúde Pública. 2001;17(2):313-322.
34. Pérez F, Carrasco E, Santos JL, Calvillán M, Albala C. Obesity and serum lipid profiles in Chilean aboriginal communities. Rev Méd Chile. 1999;127(10):1169-1175.
35. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992; 15(11):1509-1516.
36. Vieira Filho JPB. Emergência do diabetes melito tipo II entre os Xavántes. Rev Assoc Med Bras. 1996;42:61-65.
37. Bloch KT, Coutinho ESF, Lobo MSC, Oliveira JEP, Milech A. Pressão arterial, glicemia capilar e medidas antropométricas em uma população Yanomámi. Cad Saúde Pública. 1993;9(4):428-438.
38. Alvarado-Osuna C, Milian-Osuzo F, Valles- Sancges V. Prevalence de diabetes mellitus e hiperlipidemias en indígenas otomíes. Salud Pública Méx. 2001;43(5):459-463. (Pubitemid 33089832)
39. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int. 2006;70:1840-1846. (Pubitemid 44684817)
40. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world- a growing challenge. N Engl J Med. 2007;356:213-215. (Pubitemid 46143224)
41. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. (Pubitemid 37553153)
42. Corrêa TD, Namura JJ, Silva CAP, Castro MG, Meneghini A, Ferreira C. Hipertensão arterial sistêmica: atualidades sobre sua epidemiologia, diagnóstico e tratamento. Arq Med ABC. 2005;31(2):91-101.